Content about Pramipexole

December 16, 2011

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

NEW YORK — A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

The drug maker said Lyrica (pregabalin) produced statistically significant improvements in patients with RLS compared with placebo and pramipexole after 12 weeks of treatment. In the phase-3 study, A0081186, 300 mg of Lyrica, 0.25 mg of pramipexole, 0.5 mg of pramipexole or placebo was given to patients on a daily basis.

October 20, 2010

The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan...

PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.

 

The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.

 

 

October 13, 2010

Drug maker Teva Pharmaceuticals has launched a generic treatment for Parkinson’s disease, Teva said....

NORTH WALES, Pa. Drug maker Teva Pharmaceuticals has launched a generic treatment for Parkinson’s disease, Teva said.

 

The company announced the launch of pramipexole dihydrochloride tablets in the 0.75-mg strength.

 

 

The drug is a generic version of Boehringer Ingelheim’s Mirapex. Teva already offered the drug in the 0.125-mg, 0.25-mg, 0.5-mg, 0.75-mg, 1-mg and 1.5-mg strengths.

 

March 22, 2010

Less than a month after winning approval for treating early stages of Parkinson’s disease, a...

February 21, 2010

The Food and Drug Administration has approved a new treatment for Parkinson’s disease made by...

January 11, 2010

A drug made by Boehringer Ingelheim for treating Parkinson’s disease could have sales of up...

January 3, 2010

A generic drug maker has announced the availability of a treatment of the signs and...